Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/16/2010US7834146 Recombinant polypeptides associated with plants
11/16/2010US7834143 Cell surface receptor for use as tool in identifying modulators of vascular pressure
11/16/2010US7834141 Antiproliferative agents; gonadotropin releasing factor; binding to tumor and cancer cells; Chicken II GnRH analog; resistant to degradation by post-proline peptidases
11/16/2010US7834140 Polypeptide fragment of constitutive coactivator of PPARgamma
11/16/2010US7833992 biological conjugates used for drug delivery; side effect reduction
11/16/2010US7833989 siRNA targeting connective tissue growth factor (CTGF)
11/16/2010US7833988 Oncoprotein specific immunoglobulin for use as tool in tumor diagnosis and treatment; antitumor agents
11/16/2010US7833987 Small synthetic RNA, a method of preparing the same and uses thereof
11/16/2010US7833791 Lactobacilli expressing biologically active polypeptides and uses thereof
11/16/2010US7833786 Anti-IL-6 antibodies, compositions, methods and uses
11/16/2010US7833784 Zinc finger binding domains for TNN
11/16/2010US7833783 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
11/16/2010US7833773 Bacillus mHKcel cellulase
11/16/2010US7833770 heat resistant non-maltogenic exoamylase comprising amino acid sequences having replacements, coded by nucleotide sequences; genetic engineering
11/16/2010US7833769 McrA variants and uses thereof
11/16/2010US7833768 Polypeptides having phytase activity
11/16/2010US7833764 DNA encoding xylitol dehydrogenase
11/16/2010US7833763 Method for producing organic acid
11/16/2010US7833762 Method for producing L-amino acid
11/16/2010US7833759 Method of increasing complementarity in a heteroduplex
11/16/2010US7833756 Methods of labelling polynucleotides with dibenzorhodamine dyes
11/16/2010US7833755 Anti-IL-6 antibody nucleic acid molecules and methods
11/16/2010US7833754 nucleic acids improved for the expression of interleukin-12 (IL-12); improved cytokine expression in mammalian cells by optimizing all steps of gene expression of the cytokine
11/16/2010US7833753 Mixture comprising sialinated erythropoietin (EPO) for use in generating stable, human, recombinant proteins that are modified post-translationally
11/16/2010US7833752 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides
11/16/2010US7833751 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose
11/16/2010US7833750 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
11/16/2010US7833749 used as a reporter gene for cellular systems in combination with bioluminescent or chemoluminescent systems; for energy transfer systems
11/16/2010US7833748 reacting OsKSL11 with a syn-copalyl diphosphate to produce a stemodene; isolation, purification, sequencing, and functional characterization of the class I diterpene synthase sequence OsKSL11
11/16/2010US7833742 Fabry disease; X-linked inherited lysosomal storage disease characterized by severe renal impairment, angiokeratomas, and/or cardiovascular abnormalities; selecting a human alpha -Gal A preparation having a desired pharmacokinetic parameter
11/16/2010US7833741 Uncoupling of DNA insert propagation and expression of protein for phage display
11/16/2010US7833731 A protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance; kits
11/16/2010US7833728 Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
11/16/2010US7833722 Ligands for G protein-coupled receptor protein and use thereof
11/16/2010US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
11/16/2010US7833704 Methods for detecting aneuploidy using microparticle multiplex detection
11/16/2010US7833703 Method for the construction of randomized gene sequence libraries in cells
11/16/2010US7833701 Formed via enclosing biomolecules into microcapsules and spraying (via ink jets or bubble jets) onto substrate; biochips; solid phase synthesis; diagnostic networks
11/16/2010US7833697 Endothelial stem cells, populations, methods of isolation and use thereof
11/16/2010US7833538 using an immunostimulatory dinucleotide of formula CpG*, wherein C is a natural or non-natural pyrimidine nucleoside and G* is 7-deazaguanosine; for treating autoimmune disorders, such as autoimmune asthma; allergies
11/16/2010US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon
11/16/2010US7833520 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
11/16/2010CA2542871C Retroviral vectors for delivery of interfering rna
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2502657C Use of the green fluorescent protein as a screenable marker for plant transformation
11/16/2010CA2473708C A rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors
11/16/2010CA2455223C Crfr1 selective ligands
11/16/2010CA2439624C Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring of fibrosis
11/16/2010CA2439179C Methods and materials for making and using transgenic dicamba-degrading organisms
11/16/2010CA2428739C Complementing cell lines
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2366861C Compositions and methods for helper-free production of recombinant adeno-associated viruses
11/16/2010CA2352073C F0f1-atpase and dna encoding the same
11/16/2010CA2311648C Ifnar2/ifn complex
11/16/2010CA2283462C Vectors having enhanced expression and methods of making and uses thereof
11/16/2010CA2278151C Heregulin variants
11/16/2010CA2261334C Bovine polynucleotide vaccine for the intradermal route
11/16/2010CA2197804C Method for the production of recombinant proteins, plasmids and modified cells
11/16/2010CA2156048C Alkali-tolerant xylanases
11/15/2010CA2704505A1 Method and system for protein purification
11/14/2010CA2665599A1 Bacteriophage immobilization for biosensors
11/11/2010WO2010129964A1 Drug targets for prevention of arrhythmia in heart disease
11/11/2010WO2010129940A2 Archael laccases and multicopper oxidases (mcos) and their uses thereof
11/11/2010WO2010129937A2 Methods for detecting genetic variations in dna samples
11/11/2010WO2010129934A2 Methods and compositions for diagnosis of thyroid conditions
11/11/2010WO2010129919A1 Mirna expression in allergic disease
11/11/2010WO2010129917A2 Anti-cd100 antibodies and methods for using the same
11/11/2010WO2010129861A2 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
11/11/2010WO2010129853A2 TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS USING MODIFIED dsRNA BINDING DOMAINS
11/11/2010WO2010129799A2 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
11/11/2010WO2010129791A1 Rna targeting in alpha-synucleinopathies
11/11/2010WO2010129784A2 Isolated a-type fhf n-terminal domain peptides and methods of use
11/11/2010WO2010129746A2 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
11/11/2010WO2010129655A2 Natriuretic polypeptides having mutations within their disulfide rings
11/11/2010WO2010129577A2 Method for sample preparation
11/11/2010WO2010129574A1 Stress-tolerant plants expressing mannosylglycerate-producing enzymes
11/11/2010WO2010129501A1 Yield enhancement in plants by modulation of ap2 transcription factor
11/11/2010WO2010129485A2 Compositions and methods for identifying enzyme and transport protein inhibitors
11/11/2010WO2010129457A2 Vaccines against tularemia
11/11/2010WO2010129347A2 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
11/11/2010WO2010129339A2 Compositions and methods for enhancing antigen-specific immune responses
11/11/2010WO2010129310A1 Reagents and methods for producing bioactive secreted peptides
11/11/2010WO2010129287A2 Hemicellulose-degrading enzymes
11/11/2010WO2010129284A1 Inhibition of hair follicle growth by the wnt inhibitor dkk1
11/11/2010WO2010129265A2 Compositions comprising monomeric streptavidin and methods for using same
11/11/2010WO2010129041A1 Efficient light harvesting
11/11/2010WO2010129021A1 Gene therapy for neurodegenerative disorders
11/11/2010WO2010129019A2 Real-time sequencing methods and systems
11/11/2010WO2010128948A1 Method for the determination of p blood groups
11/11/2010WO2010128724A1 Primer and probe for detection of human papillomavirus, and detection method of human papillomavirus using same
11/11/2010WO2010128669A1 Gene transfer agent composition containing polyamidoamine dendron
11/11/2010WO2010128601A1 Glucuronic acid-containing glucan, process for production of same, and use of same
11/11/2010WO2010128465A1 Prevention and treatment of nosema disease in bees
11/11/2010WO2010128398A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/11/2010WO2010128182A1 Oncolytic adenoviruses for treating cancer
11/11/2010WO2010128143A1 Method of controlling o-linked glycosylation of antibodies
11/11/2010WO2010128128A1 Dhx36 / rhau knockout mice as experimental models of muscular dystrophy
11/11/2010WO2010128116A1 Dfpase enzymes from aplysia californica
11/11/2010WO2010128091A1 The use of class iib restriction endonucleases in 2nd generation sequencing applications
11/11/2010WO2010128032A1 Cho / cert cell lines
1 ... 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 ... 4023